Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
40 participants
INTERVENTIONAL
2008-01-31
2009-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Mindfulness Training on Sleep and Inflammation Among Older Adults With Sleep Problems
NCT01534338
Mindfulness Meditation for Cognition and Mood
NCT01946893
Mindfulness Meditation and Insomnia in Alzheimer Disease Caregivers
NCT03538574
Effects of Heart Rate Oscillations During Meditation on Plasma Biomarkers of Alzheimer's Disease
NCT06210035
Compassion Meditation for Older Adults
NCT03964246
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will be recruited in the Los Angeles area and randomly assigned to the 8-week Mindfulness-Based Stress Reduction (MBSR) intervention or to a wait-list. All participants will provide a blood sample and complete a psychosocial survey before and after the intervention, and complete a 60-minute neuroimaging assessment before and after the MBSR program. All participants who are randomly assigned to the wait-list will be offered the MBSR intervention after the 8-week intervention period and then complete an additional post-test assessment after completing the MBSR program (which will include a blood sample, psychosocial survey, and a neuroimaging assessment). Participants will complete neuroimaging tasks (where they will be presented with words, pictures, and sounds) before and after receiving the MBSR intervention, which will assess neural activity and regulation responses before and after mindfulness meditation training.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mindfulness-Based Stress Reduction
A standardized 8-week mindfulness meditation training program
Mindfulness-Based Stress Reduction
8-week standardized mindfulness meditation training program
Wait-List
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mindfulness-Based Stress Reduction
8-week standardized mindfulness meditation training program
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* post-menopausal and not pregnant (women only)
* Accessible geographically and willing to come to UCLA for all study related activities
Exclusion Criteria
* are not ambulatory, (c) indicate any treatment for mental health problems in the last six months
* indicate any major physical health problems in the last three months
* use medications affecting cardiovascular or endocrine function
* are left-handed
* or have metal in their bodies (including pacemakers and permanent piercings (e.g., bellyrings), but not dental fillings)
* indicate regular use of psychotropic medication or psychotherapy in the last six months
* cognitive impairment as indicated by a score lower than 23 on the Mini-Mental State examination
* smokers
* indicate feeling claustrophobic in confined spaces, such as an fMRI scanner
* weigh over 300 lbs
* indicate any use of doctor prescribed cholesterol lowering medications (e.g., statins)
* use any doctor prescribed pain medication
* indicate any implants
55 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
J. David Creswell
Post-Doctoral Fellow, Cousins Center for Psychoneuroimmunology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
J. David Creswell, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cousins Center for Psychoneuroimmunology, UCLA
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MBSR-Older-00001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.